Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-01-25 @ 4:50 AM
Study NCT ID:
NCT06863259
Status:
RECRUITING
Last Update Posted:
2025-06-13
First Post:
2025-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
Sponsor:
Children's Hospital Medical Center, Cincinnati
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-21
Start Date Type:
ACTUAL
Primary Completion Date:
2028-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-03
First Submit QC Date:
None
Study First Post Date:
2025-03-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-11
Last Update Post Date:
2025-06-13
Last Update Post Date Type:
ACTUAL